This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Antitetanus immunoglobulin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Tetanus immunoglobulin (TIG) gives passive immunity to tetanus infection.

  • helps to remove unbound tetanus toxins (1)
  • is indicated to provide immediate protection in
    • individuals with tetanus prone wounds who are not fully vaccinated (or up to date for their age) against tetanus.
    • vaccinated individuals who have a ‘high-risk’ tetanus prone wound e.g. a wound which is also heavily contaminated with manure/soil or an abscess in an injection site (2)

Since most of the tetanus prone wounds in vaccinated individuals do not require immunoglobulin, TIG should be restricted to patients in whom it is truly indicated so that supplies can be conserved for those at greatest risk (2).

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page